Influenza B virus B/Phuket/3073/2013 BVR-1B antigen (propiolactone inactivated)

DB14470ApprovedWithdrawnVaccines

A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen".

First approval: United States, 2016

Resolves to

Compound

UNIISYY92PMQJJ

What you can answer from here — as of April 02, 2025

3Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

19Marketed productsAcross 2 countries and 1 labeller

Which other approved drugs treat the same conditions as Influenza B virus B/Phuket/3073/2013 BVR-1B antigen (propiolactone inactivated), and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account